Het volume van chirurgische ingrepen en de impact ervan op ... - KCE
Het volume van chirurgische ingrepen en de impact ervan op ... - KCE
Het volume van chirurgische ingrepen en de impact ervan op ... - KCE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
66 Volume Outcome <strong>KCE</strong> reports 113<br />
Table 5.18: Pancreatic cancer surgery: Primary data selection in MCD 2004<br />
SELECTION 1 SELECTION 2 SELECTION 3<br />
ICD-9-CM (principal<br />
and secondary)<br />
diagnosis co<strong>de</strong><br />
1520 Malignant ne<strong>op</strong>lasm<br />
of duod<strong>en</strong>um<br />
1561 Malignant ne<strong>op</strong>lasm<br />
of extrahepatic bile<br />
ducts<br />
1562 Malignant ne<strong>op</strong>lasm<br />
of ampulla of Vater<br />
157x Malignant ne<strong>op</strong>lasm<br />
of pancreas<br />
STAYS SELECTED<br />
= 4 640 stays<br />
ICD-9-CM procedure<br />
co<strong>de</strong><br />
NIHDI procedure co<strong>de</strong><br />
5251 Proximal pancreatectomy 242023 Duod<strong>en</strong>o-pancreatectomy.<br />
5252 Distal pancreatectomy 242045 Left-hemipancreatectomy with<br />
pancreatico-jejunal anastomosis,<br />
or as good as total<br />
5253 Radical subtotal pancreatectomy<br />
5259 Other partial pancreatectomy<br />
526 Total pancreatectomy<br />
527 Radical pancreaticoduod<strong>en</strong>ectomy<br />
pancreatectomy ((95%).<br />
242060 Left-hemipancreatectomy or<br />
<strong>en</strong>ucleation of pancreatic tumour<br />
or extirpation of a pancreatic<br />
sequestrum.<br />
STAYS SELECTED<br />
STAYS SELECTED<br />
= 593 stays<br />
= 560 stays<br />
TOTAL STAYS SELECTED= 4 949 stays<br />
(selection 1 OR selection 2 OR selection 3)<br />
5.3.3 Definition of procedure<br />
5.3.3.1 Primary hospital stays in Minimal Clinical Data<br />
2 531 of the 4 949 selected hospital stays had a principal diagnosis of malignant<br />
ne<strong>op</strong>lasm of duod<strong>en</strong>um (4.3% i.e. 109 stays), of extrahepatic bile ducts (7.4% i.e. 186<br />
stays), of ampulla of Vater (4.4% or 110 stays) or of pancreas (84.0% i.e. 2 126 stays). As<br />
shown in Table 5.19, only 322 stays (12.7% of 2 531 stays) corresponding to 320<br />
pati<strong>en</strong>ts (17.4% of 1 824 pati<strong>en</strong>ts) had a procedure for peripancreatic cancer surgery as<br />
<strong>de</strong>scribed above.<br />
Table 5.19: Pancreatic cancer surgery: Principal diagnosis and perc<strong>en</strong>tage of<br />
cancer surgery (per stay and per pati<strong>en</strong>t)<br />
Principal diagnosis Total Stays with Total Pati<strong>en</strong>ts with<br />
number pancreatic number pancreatic cancer<br />
hospital<br />
stays<br />
cancer surgery pati<strong>en</strong>ts surgery<br />
Nbr % Nbr %<br />
1520 Malignant ne<strong>op</strong>lasm<br />
of duod<strong>en</strong>um<br />
109 24 22.0 87 24 27.6<br />
1561 Malignant ne<strong>op</strong>lasm<br />
186<br />
of extrahepatic bile ducts<br />
16 8.6 146 16 11.0<br />
1562 Malignant ne<strong>op</strong>lasm<br />
of ampulla of Vater<br />
110 36 32.7 85 36 42.4<br />
157 Malignant ne<strong>op</strong>lasm<br />
of pancreas<br />
2 126 246 11.6 1 526 244 15.99<br />
Total<br />
2 531 322 12.7 1 842 320 17.37<br />
The APR-DRGs of these 322 stays are <strong>de</strong>scribed in Table 5.20.